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Body size and outcomes on peritoneal dialysis in the United
States.
Background. Being overweight is often cited as a relative
contraindication to peritoneal dialysis. Our primary objective
was to determine whether actual mortality rates support this
opinion.
Methods. Retrospective cohort study of United States Medi-
care patients initiating dialysis between 1995 and 2000 (N 
418,021; 11% peritoneal dialysis).
Results. Seven percent were underweight [body mass index
(BMI)  18.5 kg/m2], 27% were overweight (BMI 25.0 to 29.9
kg/m2), and 23% were obese (BMI  29.9 kg/m2) at dialysis
initiation. Compared to those with normal BMI, the adjusted
odds of initiating peritoneal dialysis were 0.70 (P  0.05) in
underweight, 1.12 (P  0.05) in overweight, and 0.87 (P 
0.05) in obese subjects. Among peritoneal dialysis patients,
adjusted mortality hazard ratios in the first, second, and third
year were 1.45 (P  0.05), 1.28 (P  0.05), and 1.17 for the
underweight, respectively; 0.84 (P  0.05), 0.89 (P  0.05),
and 0.98 for the overweight, respectively; and 0.89 (P  0.05),
0.99, and 1.00 for the obese, respectively. Apart from higher
third-year mortality in the obese, associations were similar after
censoring at a switch to hemodialysis. For transplantation, the
corresponding results were 0.76 (P  0.05), 0.90 (P  0.05),
and 0.88 for the underweight, respectively; 0.95, 1.06, and 0.93
for the overweight, respectively; and 0.62 (P  0.05), 0.68, and
0.71 for the obese, respectively. For switching to hemodialysis,
hazards ratios were 0.92, 0.97, and 0.80 for the underweight,
respectively; 1.07, 1.11 (P 0.05), and 1.03 for the overweight,
respectively; and 1.28 (P  0.05), 1.29 (P  0.05), and 1.36
(P  0.05) for the obese, respectively.
Conclusion. Although less likely to initiate peritoneal dial-
ysis, overweight and obese peritoneal dialysis patients have
longer survival than those with lower BMI, not adequately
explained by lower transplantation and technique survival
rates.
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The overlapping domains of malnutrition and in-
flammation are associated with poor outcomes in dialysis
populations [1–3]. While many patients begin dialysis
therapy underweight, it is a rarely remarked-upon fact
that the proportion of patients starting dialysis over-
weight exceeds the combined proportion in the under-
weight and ideal body weight categories. It has become
apparent that weight gain has reached epidemic propor-
tions in the general population of the United States. In
a 1999 and 2000 sample of the National Health and
Nutrition Examination Survey, for example, 64.5% of
the population was overweight [4, 5]. Recent estimates
suggest that the typical patient starting dialysis therapy
is not too dissimilar, with the population mean of incident
dialysis patients falling squarely in the realm of the over-
weight. For example, the mean body mass index (BMI)
of new dialysis patients in the United States rose from
25.7 kg/m2 in 1995 to 27.2 kg/m2 in 2001 [6].
Being overweight is frequently cited as a relative con-
traindication to peritoneal dialysis. Early clinical experi-
ence with the technique showed that “excessive carbohy-
drate absorption, obesity, and high serum triglyceride
concentrations may be long-term problems in some pa-
tients” [7]. Other studies noted that uremic solute clear-
ance and abdominal herniation were potential problems,
in addition to the classic complications of catheter failure
and peritonitis [8]. A 1997 national survey of nephrolo-
gists in the United States showed that they were more
likely to recommend peritoneal dialysis, hypothetically,
for men, patients with good compliance, those with
weight less than 200 pounds, those with residual renal
function, those without diabetes, and those living in a
family setting [9]. Thus, the fact that obesity was a poten-
tial future complication appeared to have led to the opin-
ion that obesity was a relative contraindication, although
there was scanty evidence to support this view in patients
who were overweight at the initiation of therapy. Perito-
neal dialysis and hemodialysis are highly different thera-
pies. All things being equal, informed decisions to choose
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one form of dialysis might include a balance of lifestyle
considerations and life expectancy, irrespective of body
size.
METHODS
Objectives
The objectives of this study were to determine whether
BMI categories in peritoneal dialysis patients were asso-
ciated with (1) the likelihood of initiating dialysis therapy
with peritoneal dialysis as opposed to hemodialysis; (2)
survival in an intention-to-treat model, in which switches
to hemodialysis or transplantation are ignored from an
analysis perspective; (3) survival in an on-peritoneal-
dialysis model, in which follow-up is censored when
switches to hemodialysis of 60 days or longer, or trans-
plantation occur; (4) transplantation in an intention-to-
treat model, in which switches to hemodialysis of 60 days
or longer are ignored from an analysis perspective; and
(5) switches to hemodialysis of 60 days or longer in
an on-peritoneal-dialysis model, in which follow-up is
censored at death or transplantation.
Patients and measurements
The study population was the Medicare dialysis popu-
lation aged 18 years or more at initiation of dialysis
therapy between the years 1995 and 2000. The initial
mode of dialysis, weight, height, and baseline patient
characteristics, were obtained from the Centers for
Medicare and Medicaid Services (CMS) Medical Evi-
dence Report (CMS Form 2728), which is filed at the
initiation of dialysis therapy. BMI was calculated as mass
divided by height-squared, expressed in kg/m2.
BMI was then categorized based on known groupings,
as follows [10]: (1) underweight (18.5 kg/m2); (2) nor-
mal (18.5 to 24.9 kg/m2); (3) overweight (25.0 to 29.9
kg/m2); and (4) obese (30.0 kg/m2).
Analysis
The likelihood of using peritoneal dialysis, as opposed
to hemodialysis, on day 1 of dialysis therapy, was esti-
mated using a logistic regression model including all inci-
dent adult Medicare patients in 1995-2000 (N 418,021).
The logistic regression model was adjusted for incident
year, race, gender, age, diabetes as primary cause of renal
failure, employment status, baseline glomerular filtration
rate, albumin, hemoglobin, and baseline comorbidities,
including congestive heart failure, ischemic heart disease,
cardiac dysrhythmias, cerebrovascular disease, periph-
eral vascular disease, chronic obstructive pulmonary dis-
ease, tobacco use, cancer, and inability to ambulate or
transfer. All variables used in the adjustment were taken
from the CMS Medical Evidence Report.
Outcome analysis was performed on the 41,197 pa-
tients who were on peritoneal dialysis for at least 60
days on day 90 of dialysis therapy; these patients were
followed until September 30, 2001. For a patient to be
considered to have made a switch to hemodialysis, the
patient must have remained on hemodialysis for a period
of 60 days or more, with the “time” of switching calcu-
lated as the switch date plus 60 days, with deaths in the
60-day period attributed to peritoneal dialysis. Outcomes
were modeled using interval Poisson regression in which
each of the first 3 years of follow-up was modeled inde-
pendently and adjusted for the same covariates as de-
scribed in the logistic regression model above. All analy-
ses were conducted using SAS version 8.2 (SAS Institute,
Cary, NC, USA).
RESULTS
Likelihood of using peritoneal dialysis
as initial therapy
Age, gender, mode of dialysis, mode of therapy, and
BMI were known in 418,021 subjects, representing 95%
of adult Medicare patients starting dialysis patients be-
tween 1995 and 2000. Table 1 compares the baseline
characteristics of the 10.5% peritoneal dialysis and
89.5% hemodialysis patients. Four percent of peritoneal
dialysis patients were underweight, 42% had normal
BMI, 31% were overweight, and 22% were obese. The
corresponding proportions in hemodialysis patients were
7%, 43%, 27%, and 23%, respectively.
Table 1 shows the adjusted odds ratios of initiating
therapy with peritoneal dialysis. Underweight patients
were 30% less likely, and obese patients 13% less likely
to use peritoneal dialysis compared to patients in the
normal BMI category, while patients in the overweight
category were 12% more likely to initiate peritoneal
dialysis. The other associations of initial peritoneal dial-
ysis use were earlier incident year, younger age, female
gender, Caucasian race, non-Hispanic ethnicity, current
employment, glomerulonephiritis and diabetes as pri-
mary renal disease, absence of congestive heart failure,
absence of cerebrovascular disease, absence of periph-
eral vascular disease, absence of chronic obstructive pul-
monary disease, ability to ambulate and transfer, pres-
ence of cardiac dysrhythmia, tobacco use, higher baseline
estimated glomerular filtration rate, higher serum albu-
min, and higher baseline hemoglobin.
Mortality, transplantation, and switch to hemodialysis
There were 41,197 subjects on peritoneal dialysis for
at least 60 days at day 90. Figures 1 to 4 display adjusted
outcomes of this population based on BMI categories.
In intent-to-treat mortality analysis (Fig. 1), the under-
weight group had higher mortality rates. Their risk of
death was between 17% and 45% higher in the 3 years
of follow-up relative to patients in the normal group.
Patients in both the overweight and obese groups had
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Table 1. Patient characteristics and association with dialysis modality (N  418,021)
Peritoneal Adjusted
dialysis (PD) Hemodialysis (HD) odds ratio 95% CI for
Characteristic Category (10.5%) (89.5%) (PD:HD) odds ratio P value
Body mass index kg/m2 Underweight (18.5) 4% 7% 0.70 0.66–0.73 0.0001
Normal (18.5–25) 42% 43% 1.00 Reference Reference
Overweight (25–30) 31% 27% 1.12 1.09–1.14 0.0001
Obese (30) 22% 23% 0.87 0.85–0.90 0.0001
Mean (SD) 26.4 (5.9) 26.3 (6.6) — — 0.0013
Incident year 1995–1997 54% 44% 1.00 Reference Reference
1998–2000 46% 56% 0.65 0.64–0.67 0.0001
Age years 18–29 5% 3% 1.00 Reference Reference
30–44 17% 10% 0.99 0.94–1.05 0.7443
45–64 41% 32% 0.74 0.70–0.78 0.0001
65 37% 55% 0.37 0.35–0.39 0.0001
Mean (SD) 57 (15) 64 (15) — — 0.0001
Gender Male 53% 54% 1.00 Reference Reference
Female 47% 46% 1.18 1.16–1.21 0.0001
Race Caucasian 67% 55% 1.00 Reference Reference
African American 20% 30% 0.49 0.48–0.50 0.0001
Asian 3% 3% 0.80 0.76–0.85 0.0001
Other/NA 11% 13% 0.71 0.65–0.77 0.0001
Ethnicity Non-Hispanic 91% 89% 1.00 Reference Reference
Hispanic 9% 11% 0.86 0.79–0.94 0.0012
Employment status Employed 27% 14% 1.00 Reference Reference
Unemployed 38% 40% 0.60 0.58–0.62 0.0001
Retired 31% 42% 0.71 0.69–0.73 0.0001
Unknown 3% 4% 0.61 0.58–0.65 0.0001
Primary cause of renal disease Diabetes 47% 45% 1.00 Reference Reference
Hypertension 20% 26% 0.78 0.75–0.80 0.0001
Glomerulonephritis 13% 9% 1.12 1.08–1.16 0.0001
Other/NA 20% 20% 0.77 0.75–0.79 0.0001
Comorbidities Congestive heart failure 25% 35% 0.75 0.73–0.77 0.0001
Ischemic heart disease 24% 28% 0.99 0.96–1.01 0.2997
Cardiac dysrhythmia 6% 7% 1.13 1.08–1.18 0.0001
Cerebrovascular disease 7% 10% 0.90 0.86–0.94 0.0001
Peripheral vascular disease 13% 16% 0.96 0.93–0.99 0.0076
Chronic obstructive
pulmonary disease 5% 8% 0.73 0.70–0.77 0.0001
Tobacco use 6% 5% 1.06 1.01–1.10 0.0179
Cancer 3% 6% 0.73 0.69–0.77 0.0001
Unable to ambulate or
transfer 2% 5% 0.63 0.59–0.67 0.0001
Baseline glomerular filtration 5.0 15% 17% 0.65 0.63–0.67 0.0001
rate mL/min 5.0–10.0 60% 56% 0.90 0.88–0.92 0.0001
10.0 24% 26% 1.00 Reference Reference
NA 1% 1% 0.80 0.73–0.88 0.0001
Mean (SD) 8.3 (3.9) 8.4 (4.0) — — 0.0041
Baseline serum albumin g/dL 3.0 28% 42% 0.41 0.39–0.42 0.0001
3.0–3.4 24% 22% 0.65 0.63–0.67 0.0001
3.4 27% 14% 1.00 Reference Reference
NA 21% 23% 0.56 0.54–0.57 0.0001
Mean (SD) 3.4 (0.6) 3.2 (0.7) — — 0.0001
Baseline hemoglobin g/dL 11 68% 76% 0.70 0.68–0.72 0.0001
11–12 16% 11% 1.00 Reference Reference
12 11% 7% 1.12 1.07–1.16 0.0001
NA 5% 5% 0.75 0.71–0.79 0.0001
Mean (SD) 10.0 (1.8) 9.5 (1.8) — — 0.0001
NA is not available.
lower or equivalent mortality rates over the 3 years of
follow-up.
When follow-up was censored at switch to hemodialy-
sis or transplantation (Fig. 2), trends were broadly simi-
lar, with the exception that, by 3 years, hazards ratios in
the underweight group were similar to the normal BMI
group. Patients in the overweight group again displayed
lower, or equivalent, mortality rates over the 3-year pe-
riod, whereas patients in the obese group had lower
mortality rates in the first year and elevated mortality
in the third year.
Compared to those with normal BMI, patients in the
underweight group had a 24% lower adjusted trans-
plantation rate in the first year of follow-up and equiva-
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Fig. 1. Adjusted mortality rates and associ-
ated relative risks by body mass index (BMI)
category. Patients were followed on an intent-
to-treat basis, ignoring switch to hemodialysis
or transplantation. PD is peritoneal dialysis.
Fig. 2. Adjusted mortality rates and associ-
ated relative risks by body mass index (BMI)
category. Patients were censored at a switch
to hemodialysis or transplantation. PD is peri-
toneal dialysis.
Fig. 3. Adjusted transplantation rates and as-
sociated relative risks by body mass index
(BMI) category. PD is peritoneal dialysis.
lent transplantation rates in years 2 and 3 (Fig. 3). Over-
weight subjects had similar rates, while obese subjects
had lower transplantation rates in the first, second, and
third years of follow-up.
Figure 4 shows adjusted rates of changing to hemodial-
ysis according to BMI category. Compared to those in
the normal BMI group, underweight subjects had similar
switch rates, overweight subjects had higher rates in
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Fig. 4. Adjusted rates of switching to hemo-
dialysis and associated relative risks by body
mass index (BMI) category. PD is peritoneal
dialysis.
years 1 and 2, while obese subjects had higher rates in
each of the 3 years.
Outcomes of peritoneal dialysis subjects with BMI
categorized as 30 to 34.9, 35 to 39.9, and 40 or above
Twenty-three percent of peritoneal dialysis patients
had obesity, by definition. The BMI in 14.7% was be-
tween 30 and 34.9 kg/m2, 5.0% between 35.0 and 39.9
kg/m2, 1.9% between 40.0 and 49.9 kg/m2, and 1.0% had
BMI above 50 kg/m2. Outcome analyses were performed
with BMI broken into six categories: 18.5 kg/m2, 18.5
to 24.9 kg/m2, 25.0 to 29.9 kg/m2, 30.0 to 34.9 kg/m2,
35.0 to 39.9 kg/m2, and 40 kg/m2 or above. Using this
approach, intention-to-treat mortality in the first year
may have exhibited a U-shaped relationship to body
mass, as risks were statistically significantly lower than
the reference group only in the 30.0 to 34.9 kg/m2 cate-
gory. A similar profile was seen for as-treated mortality.
For transplantation and switch to hemodialysis, rate ra-
tios tended to rise monotonically through the subcatego-
ries of obesity.
DISCUSSION
We found that the association between BMI and out-
comes on peritoneal dialysis was dependent on the time
interval elapsed from inception of dialysis therapy. Obese
subjects were less likely to initiate peritoneal dialysis,
less likely to undergo transplantation, and more likely
to switch to hemodialysis, but had better survival than
those with lower BMI. Underweight patients were less
likely to use peritoneal dialysis, had higher mortality
rates, were less likely to receive a transplant, and equally
likely to switch to hemodialysis.
Several studies over many years have shown that the
association between BMI and survival in hemodialysis
patients differs from that seen in the general population.
Most recent studies have shown an inverse relationship,
with higher BMI associated with longer survival. Malnu-
trition, anorexia, inflammation, coexisting major organ
disease, and short survival are, unfortunately, common
features of chronic hemodialysis populations [1, 2]. Thus,
it should not be overly surprising to find that lower-than-
normal BMI is associated with shorter survival. How-
ever, several recent observational studies have shown
that higher mortality rates in underweight subjects and
lower mortality rates in overweight subjects both con-
tribute to this association [11–14]. The increased survival
of overweight subjects has not been explicable by the
possibility that smaller Kt/V is delivered to larger dialysis
patients with standardized dialysis prescriptions [15, 16].
The association between being overweight and having
longer survival in hemodialysis persisted when adjust-
ment was made for race and baseline comorbidity, sug-
gesting that these factors were not responsible. It is possi-
ble that being overweight or obese is a marker for the
absence of unmeasured comorbidity, both ongoing and
historical, or for the presence of less severe known co-
morbidity, issues that are difficult to address directly. It
is also possible, however, that being overweight confers
a real survival benefit in a setting that combines high
basal metabolic rate and anorexia, which appears to be
the case in hemodialysis, peritoneal dialysis, and chronic
kidney disease populations [17–19].
Few large-scale studies have examined whether being
overweight disadvantages peritoneal dialysis patients
with regard to proximate outcomes like transplantation
and switching to hemodialysis, or the ultimate outcome
of death. One prospective study of prevalent peritoneal
dialysis patients at a single Australian center in 1996
compared outcomes in the normal BMI and overweight
subgroups, defined as a BMI of 20 to 27.5 kg/m2 and
27.5 kg/m2, respectively. At baseline, overweight pa-
tients had lower dietary protein intake relative to body
weight and all were classified as well nourished using
subjective global assessment, compared to 72% in the
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normal group. Three-year mortality rates in overweight
patients were less than half those observed in the normal
BMI group, a disparity that widened when adjustment
was made for baseline comorbidity. Cardiovascular event
rates, however, were similar in overweight and normal
body weight subjects. These observations are compatible
with the hypothesis that “maintaining a higher-than-
average BMI to preserve “nutritional reserve” may help
to reduce the mortality and morbidity rates associated
with peritoneal dialysis [20]. Another recent multicenter,
prospective study compared 104 patients with a BMI
27 kg/m2 to a group of 104 with a BMI between 20 and
27 kg/m2, matched for age, gender, presence of diabetes,
and Charlson comorbidity index scores. Overall survival
and technique survival were similar over a 2-year follow-
up period [21]. A Canadian study found that patient
weight 80 kg was not associated with higher mortality.
Death rates, however, were higher in patients exhibiting
weight loss, irrespective of initial body weight [22]. Thus,
at the very least, the available literature indicates that
overweight patients do at least as well as those with
normal BMI. This suggests, indirectly, that high BMI
should not be used as a dominant criterion when choices
of dialysis treatment are being considered.
Our study has several obvious limitations. It is retro-
spective and examines BMI only at the inception of dial-
ysis therapy. While the number of comorbidity fields in
the Medical Evidence Report is extensive, the accuracy
of their completion cannot be vouchsafed. It would be
desirable to measure BMI serially, but this was not feasi-
ble within the constraints of data availability. This study
relied on weight and height measurement, and true nutri-
tional measures were not available, so that total body
water, fat mass, and fat-free mass could not be calculated.
The potential interaction between BMI and dialysis
could not be examined. We focused predominantly on
mortality, but did not examine important nonfatal out-
comes, such as cardiovascular events, infections, hospi-
talization, and metabolic complications, including new-
onset type 2 diabetes, and recalcitrant hyperlipidemia.
In addition, quality-of-life considerations could not be
addressed in this study.
We studied a large population of incident peritoneal
dialysis subjects, so that relatively precise risk estimates
could be obtained. The observed survival associations
were in broad agreement with those seen in the studies
cited above, although the strength of the mortality associ-
ation was partially dependent on the follow-up interval
chosen, and whether the analysis was performed as inten-
tion-to-treat or censored at treatment switch. It was note-
worthy that obesity was associated with a successively
greater likelihood of switching to hemodialysis in each
year of dialysis therapy. It was not possible to determine
from this study whether this was due to lifestyle consider-
ations, problems with delivering adequate uremic solute
clearance, glucose and lipid homeostasis, or peritoneal
membrane failure.
In spite of the lower use of peritoneal dialysis and earlier
transfer to hemodialysis, obese and overweight patients
had a better survival. It is conceivable that earlier switch-
ing was the reason for the better survival. However, very
similar mortality associations were seen when follow-
up was censored at a switch to hemodialysis, with the
exception of higher mortality in year 3 in the obese
category. This suggests that much of the relatively longer
survival of overweight peritoneal dialysis patients could
not be fully explained by earlier switch to hemodialysis.
The association between BMI categories and opting
for peritoneal dialysis was very similar to the association
with subsequent transplantation rates. Both the under-
weight and the obese were less likely to start peritoneal
dialysis, and if they did, less likely to receive a transplant.
It is impossible to prove, but tempting to speculate, that
overweight patients receive narrower treatment choices
than those with normal BMI. If such a bias exists, it ap-
pears to be in direct contradiction to survival estimates.
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